- published: 21 Mar 2014
- views: 9170
Create your page here
Friday, 23 December 2016
-
remove the playlistPfizer Inc.
-
remove the playlistLatest Videos
-
remove the playlistLongest Videos
- remove the playlistPfizer Inc.
- remove the playlistLatest Videos
- remove the playlistLongest Videos
back to playlist
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfizer Inc. (PFE) has acquired several big names over the years including Pharmacia, Warner-Lambert and Wyeth to become one of the world's largest research-based pharmaceutical companies.
It has also been the target of lawsuits and has had to settle with the US Department of Justice, four times in the last 10 years.
The company is the world's largest research-based pharmaceuticals firm. Its best-known products include cholesterol-lowering Lipitor, pain management drugs Celebrex and Lyrica, pneumonia vaccine Prevnar, high-blood-pressure therapy Norvasc, and erectile dysfunction treatment Viagra. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer acquired pharma rival Wyeth in a $68 billion deal in 2009.
- published: 08 Apr 2010
- views: 2827
"We at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them." - Pfizer.com
Learn more about the Center for Management Development: http://cmd.wichita.edu
Learn more about Pfizer: http://www.pfizer.com/
*Pharmaceutical footage courtesy of Pfizer.
- published: 28 Sep 2016
- views: 72
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA Companies Data is publicly available. Data and calculations have been sourced from our Team, “Sharadar”, (http://www.sharadar.com), Rufus Pollock and from the Open Knowledge Foundation. All data is licensed under the Open Data Commons Public Domain Dedication and License.
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video.
The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 16 Feb 2015
- views: 57
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
- published: 17 Aug 2010
- views: 201
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquartered in New York City, New York, with its research headquarters in Groton, Connecticut. It is among one of the world's largest pharmaceutical companies by revenues.
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin for neuropathic pain/fibromyalgia); Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib), an anti-inflammatory drug.
Pfizer was founded by cousins Charles Pfizer and Charles F. Erhart in New York City in 1849 as a manufacturer of fine chemicals. Pfizer's discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including Warner–Lambert in 2000, Pharmacia in 2003 and Wyeth in 2009. The Wyeth acquisition was the largest of the three at US$68 billion. Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since April 2004.
In September 2009, Pfizer pleaded guilty to the illegal marketing of the arthritis drug Bextra for uses unapproved by the U.S. Food and Drug Administration (FDA), and agreed to a $2.3 billion settlement, the largest health care fraud settlement at that time. Pfizer also paid the U.S. government $1.3 billion in criminal fines related to the "off-label" marketing of Bextra, the largest monetary penalty ever rendered for any crime. Called a repeat offender by prosecutors, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years.
- published: 21 Jun 2015
- views: 1347
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corporation (NYSE: S), Pfizer Inc (NYSE: PFE), Aetna Inc (NYSE: AET), Mosaic Co (NYSE: MOS), Herbalife Ltd. (NYSE: HLF) and more.
- published: 30 Jul 2013
- views: 93
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital Health Summer Summit UCSF 2015
Digital Health Summer Summit UCSF 2015
Web: http://www.digitalhealthsummit.com
Twitter: http://www.twitter.com/dhsummit | Hashtag: #dhsummer
The Digital Health Summer Summit provides a unique forum for industry veterans to share their hard-learned lessons and insider tips on this multi-faceted, fast-growing market. Attendees come to be inspired and learn, to mingle and network, and cross-pollinate ideas with innovators and key industry players.
Videos produced by: Tim Reha, Brady Ryan, New Media Synergy, LLC.
- published: 19 Jun 2015
- views: 153
We all want to increase patient safety, and all stakeholders in the healthcare supply chain benefit from using global GS1 Standards: Medical device suppliers, pharmaceutical producers, hospitals, pharmacies, authorities and patients. Learn more about how you can benefit from GS1 Standards at www.gs1.org
- published: 11 Dec 2014
- views: 48
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters.
Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
- published: 24 Oct 2016
- views: 43
Pfizer
Pfizer Inc. /ˈfaɪzər/ is an American global pharmaceutical corporation headquartered in New York City, with its research headquarters in Groton, Connecticut. It is among the world's largest pharmaceutical companies. Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004.
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin) for neuropathic pain/fibromyalgia; Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil) for erectile dysfunction; and Celebrex/Celebra (celecoxib), an anti-inflammatory drug.
Pfizer was founded in 1849 by cousins Charles Pfizer and Charles F. Erhart in New York City as a manufacturer of fine chemicals. Its discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including Warner–Lambert in 2000, Pharmacia in 2003, and Wyeth in 2009 (the largest of the three at $68 billion).
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/Pfizer
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
Inc.
Inc. may refer to:
Inc may refer to:
See also
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/Inc.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
location on Google Map
New York
New York is a state in the Northeastern United States and is the United States' 27th-most extensive, fourth-most populous, and seventh-most densely populated state. New York is bordered by New Jersey and Pennsylvania to the south and Connecticut, Massachusetts, and Vermont to the east. The state has a maritime border in the Atlantic Ocean with Rhode Island, east of Long Island, as well as an international border with the Canadian provinces of Quebec to the north and Ontario to the west and north. The state of New York, with an estimated 19.8 million residents in 2015, is often referred to as New York State to distinguish it from New York City, the state's most populous city and its economic hub.
With an estimated population of nearly 8.5 million in 2014, New York City is the most populous city in the United States and the premier gateway for legal immigration to the United States. The New York City Metropolitan Area is one of the most populous urban agglomerations in the world. New York City is a global city, exerting a significant impact upon commerce, finance, media, art, fashion, research, technology, education, and entertainment, its fast pace defining the term New York minute. The home of the United Nations Headquarters, New York City is an important center for international diplomacy and has been described as the cultural and financial capital of the world, as well as the world's most economically powerful city. New York City makes up over 40% of the population of New York State. Two-thirds of the state's population lives in the New York City Metropolitan Area, and nearly 40% live on Long Island. Both the state and New York City were named for the 17th century Duke of York, future King James II of England. The next four most populous cities in the state are Buffalo, Rochester, Yonkers, and Syracuse, while the state capital is Albany.
This page contains text from Wikipedia, the Free Encyclopedia -
https://wn.com/New_York
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
This article is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License, which means that you can copy and modify it as long as the entire work (including additions) remains under this license.
- Loading...
-
1:39Pfizer -- Largest Pharmaceutical Company In The World
Pfizer -- Largest Pharmaceutical Company In The WorldPfizer -- Largest Pharmaceutical Company In The World
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfizer Inc. (PFE) has acquired several big names over the years including Pharmacia, Warner-Lambert and Wyeth to become one of the world's largest research-based pharmaceutical companies. It has also been the target of lawsuits and has had to settle with the US Department of Justice, four times in the last 10 years. -
0:57Company Profile: Pfizer Inc.
Company Profile: Pfizer Inc.Company Profile: Pfizer Inc.
The company is the world's largest research-based pharmaceuticals firm. Its best-known products include cholesterol-lowering Lipitor, pain management drugs Celebrex and Lyrica, pneumonia vaccine Prevnar, high-blood-pressure therapy Norvasc, and erectile dysfunction treatment Viagra. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer acquired pharma rival Wyeth in a $68 billion deal in 2009. -
3:48Pfizer, Inc. | McPherson, KS
Pfizer, Inc. | McPherson, KSPfizer, Inc. | McPherson, KS
"We at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them." - Pfizer.com Learn more about the Center for Management Development: http://cmd.wichita.edu Learn more about Pfizer: http://www.pfizer.com/ *Pharmaceutical footage courtesy of Pfizer. -
2:09Pfizer Inc - Why Invest in
Pfizer Inc - Why Invest inPfizer Inc - Why Invest in
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances. Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein. DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements. EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness. FINANCIAL DATA Companies Data is publicly available. Data and calculations have been sourced from our Team, “Sharadar”, (http://www.sharadar.com), Rufus Pollock and from the Open Knowledge Foundation. All data is licensed under the Open Data Commons Public Domain Dedication and License. Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein. Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates. You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade. COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner . Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article. If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email: company@whyinvestin.com -
3:18Pfizer Inc. 2010 WBENC Conference
Pfizer Inc. 2010 WBENC ConferencePfizer Inc. 2010 WBENC Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD -
3:06Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquartered in New York City, New York, with its research headquarters in Groton, Connecticut. It is among one of the world's largest pharmaceutical companies by revenues. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin for neuropathic pain/fibromyalgia); Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib), an anti-inflammatory drug. Pfizer was founded by cousins Charles Pfizer and Charles F. Erhart in New York City in 1849 as a manufacturer of fine chemicals. Pfizer's discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including Warner–Lambert in 2000, Pharmacia in 2003 and Wyeth in 2009. The Wyeth acquisition was the largest of the three at US$68 billion. Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since April 2004. In September 2009, Pfizer pleaded guilty to the illegal marketing of the arthritis drug Bextra for uses unapproved by the U.S. Food and Drug Administration (FDA), and agreed to a $2.3 billion settlement, the largest health care fraud settlement at that time. Pfizer also paid the U.S. government $1.3 billion in criminal fines related to the "off-label" marketing of Bextra, the largest monetary penalty ever rendered for any crime. Called a repeat offender by prosecutors, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years. -
0:54Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corporation (NYSE: S), Pfizer Inc (NYSE: PFE), Aetna Inc (NYSE: AET), Mosaic Co (NYSE: MOS), Herbalife Ltd. (NYSE: HLF) and more. -
4:21Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSFJulio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital Health Summer Summit UCSF 2015 Digital Health Summer Summit UCSF 2015 Web: http://www.digitalhealthsummit.com Twitter: http://www.twitter.com/dhsummit | Hashtag: #dhsummer The Digital Health Summer Summit provides a unique forum for industry veterans to share their hard-learned lessons and insider tips on this multi-faceted, fast-growing market. Attendees come to be inspired and learn, to mingle and network, and cross-pollinate ideas with innovators and key industry players. Videos produced by: Tim Reha, Brady Ryan, New Media Synergy, LLC. -
1:13Increasing Patient Safety - Peggy Staver, Pfizer Inc.
Increasing Patient Safety - Peggy Staver, Pfizer Inc.Increasing Patient Safety - Peggy Staver, Pfizer Inc.
We all want to increase patient safety, and all stakeholders in the healthcare supply chain benefit from using global GS1 Standards: Medical device suppliers, pharmaceutical producers, hospitals, pharmacies, authorities and patients. Learn more about how you can benefit from GS1 Standards at www.gs1.org -
1:42The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
The Impact of Pro Bono: Pfizer Inc & Tailwind Track ClubThe Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters. Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
-
Pfizer -- Largest Pharmaceutical Company In The World
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfizer Inc. (PFE) has acquired several big names over the years including Pharmacia, Warner-Lambert and Wyeth to become one of the world's largest research-based pharmaceutical companies. It has also been the target of lawsuits and has had to settle with the US Department of Justice, four times in the last 10 years.
published: 21 Mar 2014 -
Company Profile: Pfizer Inc.
The company is the world's largest research-based pharmaceuticals firm. Its best-known products include cholesterol-lowering Lipitor, pain management drugs Celebrex and Lyrica, pneumonia vaccine Prevnar, high-blood-pressure therapy Norvasc, and erectile dysfunction treatment Viagra. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer acquired pharma rival Wyeth in a $68 billion deal in 2009.
published: 08 Apr 2010 -
Pfizer, Inc. | McPherson, KS
"We at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them." - Pfizer.com Learn more about the Center for Management Development: http://cmd.wichita.edu Learn more about Pfizer: http://www.pfizer.com/ *Pharmaceutical footage courtesy of Pfizer.
published: 28 Sep 2016 -
Pfizer Inc - Why Invest in
VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities. About The Video: We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy. For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us. Thank you and hope you'll enjoy. IMPORTANT INFORMATION - DISCLAIMER THIS VIDEO IS...
published: 16 Feb 2015 -
Pfizer Inc. 2010 WBENC Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
published: 17 Aug 2010 -
Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquartered in New York City, New York, with its research headquarters in Groton, Connecticut. It is among one of the world's largest pharmaceutical companies by revenues. Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin for neuropathic pain/fibromyalgia); Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib), an anti-inflammatory drug. ...
published: 21 Jun 2015 -
Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corporation (NYSE: S), Pfizer Inc (NYSE: PFE), Aetna Inc (NYSE: AET), Mosaic Co (NYSE: MOS), Herbalife Ltd. (NYSE: HLF) and more.
published: 30 Jul 2013 -
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital Health Summer Summit UCSF 2015 Digital Health Summer Summit UCSF 2015 Web: http://www.digitalhealthsummit.com Twitter: http://www.twitter.com/dhsummit | Hashtag: #dhsummer The Digital Health Summer Summit provides a unique forum for industry veterans to share their hard-learned lessons and insider tips on this multi-faceted, fast-growing market. Attendees come to be inspired and learn, to mingle and network, and cross-pollinate ideas with innovators and key industry players. Videos produced by: Tim Reha, Brady Ryan, New Media Synergy, LLC.
published: 19 Jun 2015 -
Increasing Patient Safety - Peggy Staver, Pfizer Inc.
We all want to increase patient safety, and all stakeholders in the healthcare supply chain benefit from using global GS1 Standards: Medical device suppliers, pharmaceutical producers, hospitals, pharmacies, authorities and patients. Learn more about how you can benefit from GS1 Standards at www.gs1.org
published: 11 Dec 2014 -
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters. Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
published: 24 Oct 2016
Pfizer -- Largest Pharmaceutical Company In The World
- Order: Reorder
- Duration: 1:39
- Updated: 21 Mar 2014
- views: 9170
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfizer ...
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfizer Inc. (PFE) has acquired several big names over the years including Pharmacia, Warner-Lambert and Wyeth to become one of the world's largest research-based pharmaceutical companies.
It has also been the target of lawsuits and has had to settle with the US Department of Justice, four times in the last 10 years.
https://wn.com/Pfizer_Largest_Pharmaceutical_Company_In_The_World
The New York-based giant is one of the largest pharmaceutical companies in the world, based on revenues. Known for famous drugs like Lipitor and Viagra, Pfizer Inc. (PFE) has acquired several big names over the years including Pharmacia, Warner-Lambert and Wyeth to become one of the world's largest research-based pharmaceutical companies.
It has also been the target of lawsuits and has had to settle with the US Department of Justice, four times in the last 10 years.
- published: 21 Mar 2014
- views: 9170
Company Profile: Pfizer Inc.
- Order: Reorder
- Duration: 0:57
- Updated: 08 Apr 2010
- views: 2827
The company is the world's largest research-based pharmaceuticals firm. Its best-known products include cholesterol-lowering Lipitor, pain management drugs Cele...
The company is the world's largest research-based pharmaceuticals firm. Its best-known products include cholesterol-lowering Lipitor, pain management drugs Celebrex and Lyrica, pneumonia vaccine Prevnar, high-blood-pressure therapy Norvasc, and erectile dysfunction treatment Viagra. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer acquired pharma rival Wyeth in a $68 billion deal in 2009.
https://wn.com/Company_Profile_Pfizer_Inc.
The company is the world's largest research-based pharmaceuticals firm. Its best-known products include cholesterol-lowering Lipitor, pain management drugs Celebrex and Lyrica, pneumonia vaccine Prevnar, high-blood-pressure therapy Norvasc, and erectile dysfunction treatment Viagra. Pfizer also keeps Fluffy and Fido in mind with its animal health products, including Revolution (antiparasitic). The company markets its pharmaceuticals directly to health care providers and patients; most of its sales are conducted through wholesalers including McKesson and Cardinal Health. Pfizer acquired pharma rival Wyeth in a $68 billion deal in 2009.
- published: 08 Apr 2010
- views: 2827
Pfizer, Inc. | McPherson, KS
- Order: Reorder
- Duration: 3:48
- Updated: 28 Sep 2016
- views: 72
"We at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to...
"We at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them." - Pfizer.com
Learn more about the Center for Management Development: http://cmd.wichita.edu
Learn more about Pfizer: http://www.pfizer.com/
*Pharmaceutical footage courtesy of Pfizer.
https://wn.com/Pfizer,_Inc._|_Mcpherson,_Ks
"We at Pfizer are committed to applying science and our global resources to improve health and well-being at every stage of life. We strive to provide access to safe, effective and affordable medicines and related health care services to the people who need them." - Pfizer.com
Learn more about the Center for Management Development: http://cmd.wichita.edu
Learn more about Pfizer: http://www.pfizer.com/
*Pharmaceutical footage courtesy of Pfizer.
- published: 28 Sep 2016
- views: 72
Pfizer Inc - Why Invest in
- Order: Reorder
- Duration: 2:09
- Updated: 16 Feb 2015
- views: 57
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securit...
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA Companies Data is publicly available. Data and calculations have been sourced from our Team, “Sharadar”, (http://www.sharadar.com), Rufus Pollock and from the Open Knowledge Foundation. All data is licensed under the Open Data Commons Public Domain Dedication and License.
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video.
The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
https://wn.com/Pfizer_Inc_Why_Invest_In
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA Companies Data is publicly available. Data and calculations have been sourced from our Team, “Sharadar”, (http://www.sharadar.com), Rufus Pollock and from the Open Knowledge Foundation. All data is licensed under the Open Data Commons Public Domain Dedication and License.
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video.
The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 16 Feb 2015
- views: 57
Pfizer Inc. 2010 WBENC Conference
- Order: Reorder
- Duration: 3:18
- Updated: 17 Aug 2010
- views: 201
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
https://wn.com/Pfizer_Inc._2010_Wbenc_Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
- published: 17 Aug 2010
- views: 201
Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
- Order: Reorder
- Duration: 3:06
- Updated: 21 Jun 2015
- views: 1347
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquartered in New York City, New York, with its research headquarters in Groto...
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquartered in New York City, New York, with its research headquarters in Groton, Connecticut. It is among one of the world's largest pharmaceutical companies by revenues.
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin for neuropathic pain/fibromyalgia); Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib), an anti-inflammatory drug.
Pfizer was founded by cousins Charles Pfizer and Charles F. Erhart in New York City in 1849 as a manufacturer of fine chemicals. Pfizer's discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including Warner–Lambert in 2000, Pharmacia in 2003 and Wyeth in 2009. The Wyeth acquisition was the largest of the three at US$68 billion. Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since April 2004.
In September 2009, Pfizer pleaded guilty to the illegal marketing of the arthritis drug Bextra for uses unapproved by the U.S. Food and Drug Administration (FDA), and agreed to a $2.3 billion settlement, the largest health care fraud settlement at that time. Pfizer also paid the U.S. government $1.3 billion in criminal fines related to the "off-label" marketing of Bextra, the largest monetary penalty ever rendered for any crime. Called a repeat offender by prosecutors, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years.
https://wn.com/Pfizer_Corporate_Headquarters_A_Video_Tour_Filmed_On_Sunday_June_21,_2015
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquartered in New York City, New York, with its research headquarters in Groton, Connecticut. It is among one of the world's largest pharmaceutical companies by revenues.
Pfizer develops and produces medicines and vaccines for a wide range of medical disciplines, including immunology, oncology, cardiology, diabetology/endocrinology, and neurology. Pfizer's products include the blockbuster drug Lipitor (atorvastatin), used to lower LDL blood cholesterol; Lyrica (pregabalin for neuropathic pain/fibromyalgia); Diflucan (fluconazole), an oral antifungal medication; Zithromax (azithromycin), an antibiotic; Viagra (sildenafil, for erectile dysfunction); and Celebrex/Celebra (celecoxib), an anti-inflammatory drug.
Pfizer was founded by cousins Charles Pfizer and Charles F. Erhart in New York City in 1849 as a manufacturer of fine chemicals. Pfizer's discovery of Terramycin (oxytetracycline) in 1950 put it on a path towards becoming a research-based pharmaceutical company. Pfizer has made numerous acquisitions, including Warner–Lambert in 2000, Pharmacia in 2003 and Wyeth in 2009. The Wyeth acquisition was the largest of the three at US$68 billion. Pfizer is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since April 2004.
In September 2009, Pfizer pleaded guilty to the illegal marketing of the arthritis drug Bextra for uses unapproved by the U.S. Food and Drug Administration (FDA), and agreed to a $2.3 billion settlement, the largest health care fraud settlement at that time. Pfizer also paid the U.S. government $1.3 billion in criminal fines related to the "off-label" marketing of Bextra, the largest monetary penalty ever rendered for any crime. Called a repeat offender by prosecutors, this was Pfizer's fourth such settlement with the U.S. Department of Justice in the previous ten years.
- published: 21 Jun 2015
- views: 1347
Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
- Order: Reorder
- Duration: 0:54
- Updated: 30 Jul 2013
- views: 93
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corporation (NYSE: S), Pfizer Inc (NYSE: PFE), Aetna Inc (NYSE: AET), Mosai...
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corporation (NYSE: S), Pfizer Inc (NYSE: PFE), Aetna Inc (NYSE: AET), Mosaic Co (NYSE: MOS), Herbalife Ltd. (NYSE: HLF) and more.
https://wn.com/Earnings_Buzz_Sprint_Nextel_Corporation_(S),_Chrysler_Group_Llc,_Pfizer_Inc_(Pfe)
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corporation (NYSE: S), Pfizer Inc (NYSE: PFE), Aetna Inc (NYSE: AET), Mosaic Co (NYSE: MOS), Herbalife Ltd. (NYSE: HLF) and more.
- published: 30 Jul 2013
- views: 93
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
- Order: Reorder
- Duration: 4:21
- Updated: 19 Jun 2015
- views: 153
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital Health Summer Summit UCSF 2015
Digital Health Summer Summit UCSF 2015...
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital Health Summer Summit UCSF 2015
Digital Health Summer Summit UCSF 2015
Web: http://www.digitalhealthsummit.com
Twitter: http://www.twitter.com/dhsummit | Hashtag: #dhsummer
The Digital Health Summer Summit provides a unique forum for industry veterans to share their hard-learned lessons and insider tips on this multi-faceted, fast-growing market. Attendees come to be inspired and learn, to mingle and network, and cross-pollinate ideas with innovators and key industry players.
Videos produced by: Tim Reha, Brady Ryan, New Media Synergy, LLC.
https://wn.com/Julio_Corredor,_Director,_Worldwide_Innovation,_Pfizer_Inc.,_Digital_Health_Summer_Summit_Ucsf
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital Health Summer Summit UCSF 2015
Digital Health Summer Summit UCSF 2015
Web: http://www.digitalhealthsummit.com
Twitter: http://www.twitter.com/dhsummit | Hashtag: #dhsummer
The Digital Health Summer Summit provides a unique forum for industry veterans to share their hard-learned lessons and insider tips on this multi-faceted, fast-growing market. Attendees come to be inspired and learn, to mingle and network, and cross-pollinate ideas with innovators and key industry players.
Videos produced by: Tim Reha, Brady Ryan, New Media Synergy, LLC.
- published: 19 Jun 2015
- views: 153
Increasing Patient Safety - Peggy Staver, Pfizer Inc.
- Order: Reorder
- Duration: 1:13
- Updated: 11 Dec 2014
- views: 48
We all want to increase patient safety, and all stakeholders in the healthcare supply chain benefit from using global GS1 Standards: Medical device suppliers, p...
We all want to increase patient safety, and all stakeholders in the healthcare supply chain benefit from using global GS1 Standards: Medical device suppliers, pharmaceutical producers, hospitals, pharmacies, authorities and patients. Learn more about how you can benefit from GS1 Standards at www.gs1.org
https://wn.com/Increasing_Patient_Safety_Peggy_Staver,_Pfizer_Inc.
We all want to increase patient safety, and all stakeholders in the healthcare supply chain benefit from using global GS1 Standards: Medical device suppliers, pharmaceutical producers, hospitals, pharmacies, authorities and patients. Learn more about how you can benefit from GS1 Standards at www.gs1.org
- published: 11 Dec 2014
- views: 48
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
- Order: Reorder
- Duration: 1:42
- Updated: 24 Oct 2016
- views: 43
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro b...
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters.
Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
https://wn.com/The_Impact_Of_Pro_Bono_Pfizer_Inc_Tailwind_Track_Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters.
Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
- published: 24 Oct 2016
- views: 43
-
Pfizer Inc бизнесін жіктемейтін болды
published: 29 Sep 2016 -
Pfizer Inc не будет разделять бизнес
published: 29 Sep 2016 -
-
Drug Delivery and Formulation Summit 2012: An Interview with Pfizer Inc
An Interview with Pfizer Inc at the Drug Delivery and Formulation Summit 2012 http://www.ddfsummit.com/
published: 28 Oct 2015 -
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. @BioAsia
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. at BioAsia
published: 10 Sep 2014 -
-
Hãng dược phẩm Pfizer Inc chi gần 120 tỷ USD mua đối thủ.VTC14
published: 18 Feb 2016 -
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters. Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
published: 24 Oct 2016 -
Pfizer Inc Corporate Office Contact Information
You can view Pfizer Inc office information on http://www.corporateoffice.com/Pfizer-Inc.html and get contact details for Pfizer Inc headquarters. Details include phone number, address, website, and more.
published: 25 Apr 2013 -
Pfizer Inc. 2010 WBENC Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
published: 17 Aug 2010
Pfizer Inc бизнесін жіктемейтін болды
- Order: Reorder
- Duration: 0:38
- Updated: 29 Sep 2016
- views: 0
- published: 29 Sep 2016
- views: 0
Pfizer Inc не будет разделять бизнес
- Order: Reorder
- Duration: 0:53
- Updated: 29 Sep 2016
- views: 2
- published: 29 Sep 2016
- views: 2
PFIZER INC TEE
- Order: Reorder
- Duration: 1:33
- Updated: 07 Mar 2016
- views: 1
CLICK HERE TO GET IT : http://fshirt.us/m4jac
CLICK HERE TO GET IT : http://fshirt.us/m4jac
https://wn.com/Pfizer_Inc_Tee
Drug Delivery and Formulation Summit 2012: An Interview with Pfizer Inc
- Order: Reorder
- Duration: 2:33
- Updated: 28 Oct 2015
- views: 5
An Interview with Pfizer Inc at the Drug Delivery and Formulation Summit 2012
http://www.ddfsummit.com/
An Interview with Pfizer Inc at the Drug Delivery and Formulation Summit 2012
http://www.ddfsummit.com/
https://wn.com/Drug_Delivery_And_Formulation_Summit_2012_An_Interview_With_Pfizer_Inc
An Interview with Pfizer Inc at the Drug Delivery and Formulation Summit 2012
http://www.ddfsummit.com/
- published: 28 Oct 2015
- views: 5
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. @BioAsia
- Order: Reorder
- Duration: 0:38
- Updated: 10 Sep 2014
- views: 29
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. at BioAsia
- published: 10 Sep 2014
- views: 29
Teva Canada Ltd v Pfizer Canada Inc
- Order: Reorder
- Duration: 56:25
- Updated: 07 Mar 2016
- views: 81
Hãng dược phẩm Pfizer Inc chi gần 120 tỷ USD mua đối thủ.VTC14
- Order: Reorder
- Duration: 1:23
- Updated: 18 Feb 2016
- views: 0
- published: 18 Feb 2016
- views: 0
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
- Order: Reorder
- Duration: 1:42
- Updated: 24 Oct 2016
- views: 43
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro b...
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters.
Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
https://wn.com/The_Impact_Of_Pro_Bono_Pfizer_Inc_Tailwind_Track_Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one law firm, and one individual for their incredible commitment to pro bono. Pfizer, Inc. was among the honorees, having represented nearly thirty Pro Bono Partnership clients throughout the tri-state region. Like the other honorees, Pfizer, Inc. is also one of the Partnership's valued supporters.
Watch this video to learn about the story of how Pfizer, Inc. made the difference for one of our clients, Tailwind Track Club.
- published: 24 Oct 2016
- views: 43
Pfizer Inc Corporate Office Contact Information
- Order: Reorder
- Duration: 0:38
- Updated: 25 Apr 2013
- views: 26
You can view Pfizer Inc office information on http://www.corporateoffice.com/Pfizer-Inc.html and get contact details for Pfizer Inc headquarters. Details includ...
You can view Pfizer Inc office information on http://www.corporateoffice.com/Pfizer-Inc.html and get contact details for Pfizer Inc headquarters. Details include phone number, address, website, and more.
https://wn.com/Pfizer_Inc_Corporate_Office_Contact_Information
You can view Pfizer Inc office information on http://www.corporateoffice.com/Pfizer-Inc.html and get contact details for Pfizer Inc headquarters. Details include phone number, address, website, and more.
- published: 25 Apr 2013
- views: 26
Pfizer Inc. 2010 WBENC Conference
- Order: Reorder
- Duration: 3:18
- Updated: 17 Aug 2010
- views: 201
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
https://wn.com/Pfizer_Inc._2010_Wbenc_Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in Baltimore, MD
- published: 17 Aug 2010
- views: 201
-
Early Stage DM Therapy Development at 2016 MDF Annual Conference
Dr. Lauren Wood, director of neuromuscular research in the rare disease research unit at Pfizer, Inc., presents an overview of the progress achieved in DM1 drug development at Pfizer to date, and anticipated next steps for clinical trial development – at the 2016 MDF Annual Conference.
published: 14 Oct 2016 -
Characterization of iCell Cardiomyocytes - Yvonne Will, PhD, Pfizer Inc.
The full title of the talk, "Fit for Purpose: Temporal Bioenergetic and Transcriptomic Characterization of iCell Cardiomyocytes over Extended Culture Periods" was presented at the Cellular Dynamics Workshop at SOT 2012 by Yvonne Will from Pfizer, Inc.
published: 12 Jun 2012 -
Human Genetics and Personalized Medicine, Dr. David Cox
Human Genetics, Personalized Medicine and Improved Health Outcomes: Hype or Reality? Dr. David Cox, Senior Vice President and Chief Scientific Officer Biotherapeutics and Innovation Center -- Pfizer Inc. February 24, 2012
published: 17 Apr 2014 -
Eastern Fellows Panel Discussion 9/21/16
Panelists include: Tracey Boyden ’89 (Biology), a principal scientist at Pfizer, Inc., who owns several patents and develops drug therapies used to treat diseases ranging from cancer to neurological disorders; Cynthia Konney ’77 (Environmental Earth Science), a certified gemologist who is a nationally recognized expert in gemology and jewelry appraisal; and Andrew Zlotnick ’85 (Environmental Earth Science), senior vice president for the environmental engineering and consulting firm Fuss & O’Neill.
published: 10 Oct 2016 -
National Committee on U.S.-China Relations 2015 Gala Dinner
The National Committee on U.S.-China Relations’ 2015 Annual Gala Dinner included remarks by honorees Stephen A. Schwarzman, Chairman & CEO of Blackstone and Ian C. Read, Chairman & CEO of Pfizer, Inc., and a keynote address by Cui Tiankai, China’s Ambassador to the United States of America. The black-tie event welcomed more than 500 guests on Wednesday, October 14, 2015 at the Plaza in New York City. The National Committee on U.S.-China Relations is the leading nonprofit nonpartisan organization that encourages understanding of China and the United States among citizens of both countries.
published: 19 Oct 2015 -
向錢汗 （Sweatin’ Money!） EP14: SQ, V, MA, AAPL, TWTR, PFE, AGN, WMT, MCD
In this episode, we talked about: -Square IPO and the CEO. -Airport strikes. -Oil prices. -Pfizer and Allergan merger. Please check out the actual page (http://mny.congkeringpath.com/?p=24) for links to the webpages we cited. Companies mentioned: Square Inc (SQ) Visa (V) MasterCard (MA) Apple (AAPL) Twitter (TWTR) Pfizer Inc(PFE) Allergan (AGN) Wal-Mart(WMT) McDonald’s (MCD)
published: 24 Nov 2015 -
Morris Morrison Interviewed by Chuck Gallagher on Straight Talk Radio
Why is there so much energy and buzz with Morrison Global Brands? It’s simple, top organizations in the world such as Microsoft and The National Basketball Association, and many top colleges & universities - have experienced the story of a global brand that sounds like a script that was written in Hollywood! And he's my guest on Straight Talk Radio. http://chuckgallagher.com Check out Morris's new book - Overnight Success! After being born in New York City, Morris Morrison was orphaned by the death of his birth parents. As a teen, he found himself on his own once again after the loss of his adoptive parents. After finding a way to transition through the adversity that he faced early in life, Morris Morrison learned a secret: the secret advantage that you develop after experiencing t...
published: 06 Jan 2016 -
Travel Series - Hiking New Zealand
Local resident Ralph Robinson will share his experience of hiking the world-famous Milford and Routeburn Tracks in New Zealand’s stunning Fiordland National Park, a remote land of lush temperate rainforests, rugged snow-peaked mountains, spectacular lakes and waterfalls, and amazing coastal scenery. Married to an Australian and having lived in Australia for three years, Robinson has traveled extensively Down Under, both in Australia and New Zealand. He has been an avid hiker all his life with extensive experience Down Under as well as in New Hampshire’s White Mountains. Robinson is originally from Portland, Connecticut and is employed at Pfizer, Inc. as a medicinal chemist in the Global R&D; division.
published: 27 Oct 2016 -
Focus on Lung Cancer: From Screening to Diagnosis and Treatment.
Panel Discussion:“Focus on Lung Cancer: From Screening to Diagnosis and Treatment” View a recorded panel discussion, “Focus on Lung Cancer: From Screening to Diagnosis and Treatment,” that occurred at the ACCC National Oncology Conference, in San Diego, October 2014. The panelists cover learnings from two separate projects: 1) ACCC’s Learning Labs for Process Improvement project, as well as 2) The Biomarker Testing Service Redesign Project at St. Joseph Hospital, Orange County. Funding and support for both projects was provided by Pfizer, Inc.
published: 20 Jan 2015
Early Stage DM Therapy Development at 2016 MDF Annual Conference
- Order: Reorder
- Duration: 35:59
- Updated: 14 Oct 2016
- views: 53
Dr. Lauren Wood, director of neuromuscular research in the rare disease research unit at Pfizer, Inc., presents an overview of the progress achieved in DM1 drug...
Dr. Lauren Wood, director of neuromuscular research in the rare disease research unit at Pfizer, Inc., presents an overview of the progress achieved in DM1 drug development at Pfizer to date, and anticipated next steps for clinical trial development – at the 2016 MDF Annual Conference.
https://wn.com/Early_Stage_Dm_Therapy_Development_At_2016_Mdf_Annual_Conference
Dr. Lauren Wood, director of neuromuscular research in the rare disease research unit at Pfizer, Inc., presents an overview of the progress achieved in DM1 drug development at Pfizer to date, and anticipated next steps for clinical trial development – at the 2016 MDF Annual Conference.
- published: 14 Oct 2016
- views: 53
Characterization of iCell Cardiomyocytes - Yvonne Will, PhD, Pfizer Inc.
- Order: Reorder
- Duration: 32:03
- Updated: 12 Jun 2012
- views: 321
The full title of the talk, "Fit for Purpose: Temporal Bioenergetic and Transcriptomic Characterization of iCell Cardiomyocytes over Extended Culture Periods" w...
The full title of the talk, "Fit for Purpose: Temporal Bioenergetic and Transcriptomic Characterization of iCell Cardiomyocytes over Extended Culture Periods" was presented at the Cellular Dynamics Workshop at SOT 2012 by Yvonne Will from Pfizer, Inc.
https://wn.com/Characterization_Of_Icell_Cardiomyocytes_Yvonne_Will,_Phd,_Pfizer_Inc.
Human Genetics and Personalized Medicine, Dr. David Cox
- Order: Reorder
- Duration: 1:48:15
- Updated: 17 Apr 2014
- views: 228
Human Genetics, Personalized Medicine and Improved Health Outcomes: Hype or Reality?
Dr. David Cox, Senior Vice President and Chief Scientific Officer Biothera...
Human Genetics, Personalized Medicine and Improved Health Outcomes: Hype or Reality?
Dr. David Cox, Senior Vice President and Chief Scientific Officer Biotherapeutics and Innovation Center -- Pfizer Inc. February 24, 2012
https://wn.com/Human_Genetics_And_Personalized_Medicine,_Dr._David_Cox
Human Genetics, Personalized Medicine and Improved Health Outcomes: Hype or Reality?
Dr. David Cox, Senior Vice President and Chief Scientific Officer Biotherapeutics and Innovation Center -- Pfizer Inc. February 24, 2012
- published: 17 Apr 2014
- views: 228
Eastern Fellows Panel Discussion 9/21/16
- Order: Reorder
- Duration: 57:20
- Updated: 10 Oct 2016
- views: 8
Panelists include: Tracey Boyden ’89 (Biology), a principal scientist at Pfizer, Inc., who owns several patents and develops drug therapies used to treat disea...
Panelists include: Tracey Boyden ’89 (Biology), a principal scientist at Pfizer, Inc., who owns several patents and develops drug therapies used to treat diseases ranging from cancer to neurological disorders; Cynthia Konney ’77 (Environmental Earth Science), a certified gemologist who is a nationally recognized expert in gemology and jewelry appraisal; and Andrew Zlotnick ’85 (Environmental Earth Science), senior vice president for the environmental engineering and consulting firm Fuss & O’Neill.
https://wn.com/Eastern_Fellows_Panel_Discussion_9_21_16
Panelists include: Tracey Boyden ’89 (Biology), a principal scientist at Pfizer, Inc., who owns several patents and develops drug therapies used to treat diseases ranging from cancer to neurological disorders; Cynthia Konney ’77 (Environmental Earth Science), a certified gemologist who is a nationally recognized expert in gemology and jewelry appraisal; and Andrew Zlotnick ’85 (Environmental Earth Science), senior vice president for the environmental engineering and consulting firm Fuss & O’Neill.
- published: 10 Oct 2016
- views: 8
National Committee on U.S.-China Relations 2015 Gala Dinner
- Order: Reorder
- Duration: 1:08:12
- Updated: 19 Oct 2015
- views: 245
The National Committee on U.S.-China Relations’ 2015 Annual Gala Dinner included remarks by honorees Stephen A. Schwarzman, Chairman & CEO of Blackstone and Ian...
The National Committee on U.S.-China Relations’ 2015 Annual Gala Dinner included remarks by honorees Stephen A. Schwarzman, Chairman & CEO of Blackstone and Ian C. Read, Chairman & CEO of Pfizer, Inc., and a keynote address by Cui Tiankai, China’s Ambassador to the United States of America. The black-tie event welcomed more than 500 guests on Wednesday, October 14, 2015 at the Plaza in New York City.
The National Committee on U.S.-China Relations is the leading nonprofit nonpartisan organization that encourages understanding of China and the United States among citizens of both countries.
https://wn.com/National_Committee_On_U.S._China_Relations_2015_Gala_Dinner
The National Committee on U.S.-China Relations’ 2015 Annual Gala Dinner included remarks by honorees Stephen A. Schwarzman, Chairman & CEO of Blackstone and Ian C. Read, Chairman & CEO of Pfizer, Inc., and a keynote address by Cui Tiankai, China’s Ambassador to the United States of America. The black-tie event welcomed more than 500 guests on Wednesday, October 14, 2015 at the Plaza in New York City.
The National Committee on U.S.-China Relations is the leading nonprofit nonpartisan organization that encourages understanding of China and the United States among citizens of both countries.
- published: 19 Oct 2015
- views: 245
向錢汗 （Sweatin’ Money!） EP14: SQ, V, MA, AAPL, TWTR, PFE, AGN, WMT, MCD
- Order: Reorder
- Duration: 1:06:56
- Updated: 24 Nov 2015
- views: 13
In this episode, we talked about:
-Square IPO and the CEO.
-Airport strikes.
-Oil prices.
-Pfizer and Allergan merger.
Please check out the actual page (http:/...
In this episode, we talked about:
-Square IPO and the CEO.
-Airport strikes.
-Oil prices.
-Pfizer and Allergan merger.
Please check out the actual page (http://mny.congkeringpath.com/?p=24) for links to the webpages we cited.
Companies mentioned:
Square Inc (SQ)
Visa (V)
MasterCard (MA)
Apple (AAPL)
Twitter (TWTR)
Pfizer Inc(PFE)
Allergan (AGN)
Wal-Mart(WMT)
McDonald’s (MCD)
https://wn.com/向錢汗_（Sweatin’_Money_）_Ep14_Sq,_V,_Ma,_Aapl,_Twtr,_Pfe,_Agn,_Wmt,_Mcd
In this episode, we talked about:
-Square IPO and the CEO.
-Airport strikes.
-Oil prices.
-Pfizer and Allergan merger.
Please check out the actual page (http://mny.congkeringpath.com/?p=24) for links to the webpages we cited.
Companies mentioned:
Square Inc (SQ)
Visa (V)
MasterCard (MA)
Apple (AAPL)
Twitter (TWTR)
Pfizer Inc(PFE)
Allergan (AGN)
Wal-Mart(WMT)
McDonald’s (MCD)
- published: 24 Nov 2015
- views: 13
Morris Morrison Interviewed by Chuck Gallagher on Straight Talk Radio
- Order: Reorder
- Duration: 48:01
- Updated: 06 Jan 2016
- views: 3160
Why is there so much energy and buzz with Morrison Global Brands? It’s simple, top organizations in the world such as Microsoft and The National Basketball Ass...
Why is there so much energy and buzz with Morrison Global Brands? It’s simple, top organizations in the world such as Microsoft and The National Basketball Association, and many top colleges & universities - have experienced the story of a global brand that sounds like a script that was written in Hollywood! And he's my guest on Straight Talk Radio. http://chuckgallagher.com
Check out Morris's new book - Overnight Success!
After being born in New York City, Morris Morrison was orphaned by the death of his birth parents. As a teen, he found himself on his own once again after the loss of his adoptive parents. After finding a way to transition through the adversity that he faced early in life, Morris Morrison learned a secret: the secret advantage that you develop after experiencing tough challenges - Motivation! Morris used this motivation to shape his mindset towards personal and professional development. After he received his Bachelors and Masters Degree's from Fairmont State University and West Virginia University, Morris Morrison continued his learning and development as he successfully navigated the ranks of some the worlds top corporations such as Equitable Resources, BB&T; Bank, and Pfizer Inc. - in professional roles spanning from HR and Talent Management to Sales and Business Development.
Today, in his primary role, Morris Morrison serves as Lisa’s Husband and Baby Dori’s Dad. He also runs and operates Morrison Global Brands, where he uses the same mindset towards personal & professional development to help organizations and individuals succeed. He and his talented team of professionals provide products and services that help individuals and organizations have the energy, skills and capacity to perform better. He is also a co-founder and managing partner of PRO2CEO - a business consulting firm developed to help high-performing professionals transition to new business opportunities while remaining successful at the high levels.
So now, it's YOUR turn! If you are ready to partner with Morrison Global Brands to equip and energize your people to perform at their highest level, give us a call and get ready for the Morris Global Brands Experience!
To connect with Morris Morrison visit here: http://www.morrisonglobal.us/home.html
https://wn.com/Morris_Morrison_Interviewed_By_Chuck_Gallagher_On_Straight_Talk_Radio
Why is there so much energy and buzz with Morrison Global Brands? It’s simple, top organizations in the world such as Microsoft and The National Basketball Association, and many top colleges & universities - have experienced the story of a global brand that sounds like a script that was written in Hollywood! And he's my guest on Straight Talk Radio. http://chuckgallagher.com
Check out Morris's new book - Overnight Success!
After being born in New York City, Morris Morrison was orphaned by the death of his birth parents. As a teen, he found himself on his own once again after the loss of his adoptive parents. After finding a way to transition through the adversity that he faced early in life, Morris Morrison learned a secret: the secret advantage that you develop after experiencing tough challenges - Motivation! Morris used this motivation to shape his mindset towards personal and professional development. After he received his Bachelors and Masters Degree's from Fairmont State University and West Virginia University, Morris Morrison continued his learning and development as he successfully navigated the ranks of some the worlds top corporations such as Equitable Resources, BB&T; Bank, and Pfizer Inc. - in professional roles spanning from HR and Talent Management to Sales and Business Development.
Today, in his primary role, Morris Morrison serves as Lisa’s Husband and Baby Dori’s Dad. He also runs and operates Morrison Global Brands, where he uses the same mindset towards personal & professional development to help organizations and individuals succeed. He and his talented team of professionals provide products and services that help individuals and organizations have the energy, skills and capacity to perform better. He is also a co-founder and managing partner of PRO2CEO - a business consulting firm developed to help high-performing professionals transition to new business opportunities while remaining successful at the high levels.
So now, it's YOUR turn! If you are ready to partner with Morrison Global Brands to equip and energize your people to perform at their highest level, give us a call and get ready for the Morris Global Brands Experience!
To connect with Morris Morrison visit here: http://www.morrisonglobal.us/home.html
- published: 06 Jan 2016
- views: 3160
Travel Series - Hiking New Zealand
- Order: Reorder
- Duration: 37:01
- Updated: 27 Oct 2016
- views: 42
Local resident Ralph Robinson will share his experience of hiking the world-famous Milford and Routeburn Tracks in New Zealand’s stunning Fiordland National Par...
Local resident Ralph Robinson will share his experience of hiking the world-famous Milford and Routeburn Tracks in New Zealand’s stunning Fiordland National Park, a remote land of lush temperate rainforests, rugged snow-peaked mountains, spectacular lakes and waterfalls, and amazing coastal scenery. Married to an Australian and having lived in Australia for three years, Robinson has traveled extensively Down Under, both in Australia and New Zealand. He has been an avid hiker all his life with extensive experience Down Under as well as in New Hampshire’s White Mountains. Robinson is originally from Portland, Connecticut and is employed at Pfizer, Inc. as a medicinal chemist in the Global R&D; division.
https://wn.com/Travel_Series_Hiking_New_Zealand
Local resident Ralph Robinson will share his experience of hiking the world-famous Milford and Routeburn Tracks in New Zealand’s stunning Fiordland National Park, a remote land of lush temperate rainforests, rugged snow-peaked mountains, spectacular lakes and waterfalls, and amazing coastal scenery. Married to an Australian and having lived in Australia for three years, Robinson has traveled extensively Down Under, both in Australia and New Zealand. He has been an avid hiker all his life with extensive experience Down Under as well as in New Hampshire’s White Mountains. Robinson is originally from Portland, Connecticut and is employed at Pfizer, Inc. as a medicinal chemist in the Global R&D; division.
- published: 27 Oct 2016
- views: 42
Focus on Lung Cancer: From Screening to Diagnosis and Treatment.
- Order: Reorder
- Duration: 33:57
- Updated: 20 Jan 2015
- views: 139
Panel Discussion:“Focus on Lung Cancer: From Screening to Diagnosis and Treatment”
View a recorded panel discussion, “Focus on Lung Cancer: From Screening to D...
Panel Discussion:“Focus on Lung Cancer: From Screening to Diagnosis and Treatment”
View a recorded panel discussion, “Focus on Lung Cancer: From Screening to Diagnosis and Treatment,” that occurred at the ACCC National Oncology Conference, in San Diego, October 2014. The panelists cover learnings from two separate projects: 1) ACCC’s Learning Labs for Process Improvement project, as well as 2) The Biomarker Testing Service Redesign Project at St. Joseph Hospital, Orange County. Funding and support for both projects was provided by Pfizer, Inc.
https://wn.com/Focus_On_Lung_Cancer_From_Screening_To_Diagnosis_And_Treatment.
Panel Discussion:“Focus on Lung Cancer: From Screening to Diagnosis and Treatment”
View a recorded panel discussion, “Focus on Lung Cancer: From Screening to Diagnosis and Treatment,” that occurred at the ACCC National Oncology Conference, in San Diego, October 2014. The panelists cover learnings from two separate projects: 1) ACCC’s Learning Labs for Process Improvement project, as well as 2) The Biomarker Testing Service Redesign Project at St. Joseph Hospital, Orange County. Funding and support for both projects was provided by Pfizer, Inc.
- published: 20 Jan 2015
- views: 139
back
- Playlist
- Chat
back
- Playlist
- Chat
1:39
Pfizer -- Largest Pharmaceutical Company In The World
The New York-based giant is one of the largest pharmaceutical companies in the world, base...
published: 21 Mar 2014
Pfizer -- Largest Pharmaceutical Company In The World
Pfizer -- Largest Pharmaceutical Company In The World
- Report rights infringement
- published: 21 Mar 2014
- views: 9170
0:57
Company Profile: Pfizer Inc.
The company is the world's largest research-based pharmaceuticals firm. Its best-known pro...
published: 08 Apr 2010
Company Profile: Pfizer Inc.
Company Profile: Pfizer Inc.
- Report rights infringement
- published: 08 Apr 2010
- views: 2827
3:48
Pfizer, Inc. | McPherson, KS
"We at Pfizer are committed to applying science and our global resources to improve health...
published: 28 Sep 2016
Pfizer, Inc. | McPherson, KS
Pfizer, Inc. | McPherson, KS
- Report rights infringement
- published: 28 Sep 2016
- views: 72
2:09
Pfizer Inc - Why Invest in
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you c...
published: 16 Feb 2015
Pfizer Inc - Why Invest in
Pfizer Inc - Why Invest in
- Report rights infringement
- published: 16 Feb 2015
- views: 57
3:18
Pfizer Inc. 2010 WBENC Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in...
published: 17 Aug 2010
Pfizer Inc. 2010 WBENC Conference
Pfizer Inc. 2010 WBENC Conference
- Report rights infringement
- published: 17 Aug 2010
- views: 201
3:06
Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
Pfizer, Inc. /ˈfaɪzər/ is an American multinational pharmaceutical corporation headquarter...
published: 21 Jun 2015
Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
Pfizer Corporate Headquarters -- A Video Tour -- filmed on Sunday June 21, 2015
- Report rights infringement
- published: 21 Jun 2015
- views: 1347
0:54
Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
U.S. stocks climbed on Tuesday after earnings from Chrysler Group LLC, Sprint Nextel Corpo...
published: 30 Jul 2013
Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
Earnings Buzz: Sprint Nextel Corporation (S), Chrysler Group LLC, Pfizer Inc (PFE)
- Report rights infringement
- published: 30 Jul 2013
- views: 93
4:21
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., with Leslie Zigler, Digital H...
published: 19 Jun 2015
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
Julio Corredor, Director, Worldwide Innovation, Pfizer Inc., Digital Health Summer Summit UCSF
- Report rights infringement
- published: 19 Jun 2015
- views: 153
1:13
Increasing Patient Safety - Peggy Staver, Pfizer Inc.
We all want to increase patient safety, and all stakeholders in the healthcare supply chai...
published: 11 Dec 2014
Increasing Patient Safety - Peggy Staver, Pfizer Inc.
Increasing Patient Safety - Peggy Staver, Pfizer Inc.
- Report rights infringement
- published: 11 Dec 2014
- views: 48
1:42
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one...
published: 24 Oct 2016
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
- Report rights infringement
- published: 24 Oct 2016
- views: 43
back
- Playlist
- Chat
0:38
Pfizer Inc бизнесін жіктемейтін болды
published: 29 Sep 2016
Pfizer Inc бизнесін жіктемейтін болды
Pfizer Inc бизнесін жіктемейтін болды
- Report rights infringement
- published: 29 Sep 2016
- views: 0
0:53
Pfizer Inc не будет разделять бизнес
published: 29 Sep 2016
Pfizer Inc не будет разделять бизнес
Pfizer Inc не будет разделять бизнес
- Report rights infringement
- published: 29 Sep 2016
- views: 2
1:33
PFIZER INC TEE
CLICK HERE TO GET IT : http://fshirt.us/m4jac
published: 07 Mar 2016
PFIZER INC TEE
PFIZER INC TEE
- Report rights infringement
- published: 07 Mar 2016
- views: 1
2:33
Drug Delivery and Formulation Summit 2012: An Interview with Pfizer Inc
An Interview with Pfizer Inc at the Drug Delivery and Formulation Summit 2012
http://www.d...
published: 28 Oct 2015
Drug Delivery and Formulation Summit 2012: An Interview with Pfizer Inc
Drug Delivery and Formulation Summit 2012: An Interview with Pfizer Inc
- Report rights infringement
- published: 28 Oct 2015
- views: 5
0:38
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. @BioAsia
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. at BioAsia
published: 10 Sep 2014
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. @BioAsia
Dr. Freda Lewis-Hall, Chief Medical officer, Pfizer INC. @BioAsia
- Report rights infringement
- published: 10 Sep 2014
- views: 29
56:25
Teva Canada Ltd v Pfizer Canada Inc
Teva Canada Ltd v Pfizer Canada Inc
published: 07 Mar 2016
Teva Canada Ltd v Pfizer Canada Inc
Teva Canada Ltd v Pfizer Canada Inc
- Report rights infringement
- published: 07 Mar 2016
- views: 81
1:23
Hãng dược phẩm Pfizer Inc chi gần 120 tỷ USD mua đối thủ.VTC14
published: 18 Feb 2016
Hãng dược phẩm Pfizer Inc chi gần 120 tỷ USD mua đối thủ.VTC14
Hãng dược phẩm Pfizer Inc chi gần 120 tỷ USD mua đối thủ.VTC14
- Report rights infringement
- published: 18 Feb 2016
- views: 0
1:42
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
At our 2016 Gala on OCtober 18, 2016, Pro Bono Partnership honored three corporations, one...
published: 24 Oct 2016
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
The Impact of Pro Bono: Pfizer Inc & Tailwind Track Club
- Report rights infringement
- published: 24 Oct 2016
- views: 43
0:38
Pfizer Inc Corporate Office Contact Information
You can view Pfizer Inc office information on http://www.corporateoffice.com/Pfizer-Inc.ht...
published: 25 Apr 2013
Pfizer Inc Corporate Office Contact Information
Pfizer Inc Corporate Office Contact Information
- Report rights infringement
- published: 25 Apr 2013
- views: 26
3:18
Pfizer Inc. 2010 WBENC Conference
MBEConnect interview with Pfizer Inc on Supplier Diversity at the 2010 WBENC Conference in...
published: 17 Aug 2010
Pfizer Inc. 2010 WBENC Conference
Pfizer Inc. 2010 WBENC Conference
- Report rights infringement
- published: 17 Aug 2010
- views: 201
back
- Playlist
- Chat
35:59
Early Stage DM Therapy Development at 2016 MDF Annual Conference
Dr. Lauren Wood, director of neuromuscular research in the rare disease research unit at P...
published: 14 Oct 2016
Early Stage DM Therapy Development at 2016 MDF Annual Conference
Early Stage DM Therapy Development at 2016 MDF Annual Conference
- Report rights infringement
- published: 14 Oct 2016
- views: 53
32:03
Characterization of iCell Cardiomyocytes - Yvonne Will, PhD, Pfizer Inc.
The full title of the talk, "Fit for Purpose: Temporal Bioenergetic and Transcriptomic Cha...
published: 12 Jun 2012
Characterization of iCell Cardiomyocytes - Yvonne Will, PhD, Pfizer Inc.
Characterization of iCell Cardiomyocytes - Yvonne Will, PhD, Pfizer Inc.
- Report rights infringement
- published: 12 Jun 2012
- views: 321
1:48:15
Human Genetics and Personalized Medicine, Dr. David Cox
Human Genetics, Personalized Medicine and Improved Health Outcomes: Hype or Reality?
Dr. ...
published: 17 Apr 2014
Human Genetics and Personalized Medicine, Dr. David Cox
Human Genetics and Personalized Medicine, Dr. David Cox
- Report rights infringement
- published: 17 Apr 2014
- views: 228
57:20
Eastern Fellows Panel Discussion 9/21/16
Panelists include: Tracey Boyden ’89 (Biology), a principal scientist at Pfizer, Inc., wh...
published: 10 Oct 2016
Eastern Fellows Panel Discussion 9/21/16
Eastern Fellows Panel Discussion 9/21/16
- Report rights infringement
- published: 10 Oct 2016
- views: 8
1:08:12
National Committee on U.S.-China Relations 2015 Gala Dinner
The National Committee on U.S.-China Relations’ 2015 Annual Gala Dinner included remarks b...
published: 19 Oct 2015
National Committee on U.S.-China Relations 2015 Gala Dinner
National Committee on U.S.-China Relations 2015 Gala Dinner
- Report rights infringement
- published: 19 Oct 2015
- views: 245
1:06:56
向錢汗 （Sweatin’ Money!） EP14: SQ, V, MA, AAPL, TWTR, PFE, AGN, WMT, MCD
In this episode, we talked about:
-Square IPO and the CEO.
-Airport strikes.
-Oil prices.
...
published: 24 Nov 2015
向錢汗 （Sweatin’ Money!） EP14: SQ, V, MA, AAPL, TWTR, PFE, AGN, WMT, MCD
向錢汗 （Sweatin’ Money!） EP14: SQ, V, MA, AAPL, TWTR, PFE, AGN, WMT, MCD
- Report rights infringement
- published: 24 Nov 2015
- views: 13
48:01
Morris Morrison Interviewed by Chuck Gallagher on Straight Talk Radio
Why is there so much energy and buzz with Morrison Global Brands? It’s simple, top organi...
published: 06 Jan 2016
Morris Morrison Interviewed by Chuck Gallagher on Straight Talk Radio
Morris Morrison Interviewed by Chuck Gallagher on Straight Talk Radio
- Report rights infringement
- published: 06 Jan 2016
- views: 3160
37:01
Travel Series - Hiking New Zealand
Local resident Ralph Robinson will share his experience of hiking the world-famous Milford...
published: 27 Oct 2016
Travel Series - Hiking New Zealand
Travel Series - Hiking New Zealand
- Report rights infringement
- published: 27 Oct 2016
- views: 42
33:57
Focus on Lung Cancer: From Screening to Diagnosis and Treatment.
Panel Discussion:“Focus on Lung Cancer: From Screening to Diagnosis and Treatment”
View a...
published: 20 Jan 2015
Focus on Lung Cancer: From Screening to Diagnosis and Treatment.
Focus on Lung Cancer: From Screening to Diagnosis and Treatment.
- Report rights infringement
- published: 20 Jan 2015
- views: 139
Early Stage DM Therapy Development at 2016 MDF Ann...
Characterization of iCell Cardiomyocytes - Yvonne ...
Human Genetics and Personalized Medicine, Dr. Davi...
Eastern Fellows Panel Discussion 9/21/16...
National Committee on U.S.-China Relations 2015 Ga...
向錢汗 （Sweatin’ Money!） EP14: SQ, V, MA, AAPL, TWTR,...
Morris Morrison Interviewed by Chuck Gallagher on ...
Travel Series - Hiking New Zealand...
Focus on Lung Cancer: From Screening to Diagnosis ...
back
Former UK ambassador to Syria accuses Foreign Office of lying about the country's civil war
Edit The Independent 23 Dec 2016
Read more ....
back
Hands Across The Trenches – Time To Again Grasp 1914 Christmas Truce
Edit WorldNews.com 23 Dec 2016
Article by WN.com Correspondent Dallas DArlingWith gun in hand and pacing around his victim yelling “Don‘t forget Syria! Don’t forget Aleppo,” 22-year Mevlut Mert Altintas, a Turkish police officer, had just killed Andrei Karlov, Russia’s Ambassador to Turkey. Moments later, he too found out those who live by the gun die by the gun, just like the ambassador and Aleppo, Syria ... Peaceful cultural convergence had indeed won again....
back
Chinese media alarmed at Donald Trump trade adviser, warn of US showdown
Edit DNA India 23 Dec 2016
Chinese state media on Friday expressed alarm and warned of a "showdown with the US" after President-elect Donald Trump named Peter Navarro, an economist who has urged a hard line against China, to head a new White House National Trade Council. Navarro is an academic and one-time investment adviser who has authored books such as "Death by China. How America Lost its Manufacturing Base" ... ....
back
Berlin truck attack suspect killed in Milan police shootout
Edit Atlanta Journal 23 Dec 2016
ROME. The Tunisian man suspected of driving a truck into a crowded Christmas market in Berlin was killed early Friday in a shootout with police in Milan, ending a Europe-wide manhunt, Italy's interior minister said. Checks conducted after the shootout showed "the person killed, without a shadow of a doubt, is Anis Amri, the suspect of the terrorist attack," Interior Minister Marco Minniti said ... The other officer fatally shot Amri ... ....
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca
Edit Pharmiweb 23 Dec 2016
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca. Pfize... Pfizer Inc ... ....
BRIEF-AstraZeneca completes sale of antibiotics business to Pfizer
Edit Reuters 23 Dec 2016
* Has completed agreement with Pfizer Inc for sale of commercialisation and development rights to its late-stage small molecule antibiotics business ....
Pfizer Completes Acquisition of Small Molecule Anti-Infective Business From AstraZeneca (Pfizer Inc)
Edit Public Technologies 23 Dec 2016
Pfizer Inc). Pfizer Inc ... Additionally this acquisition is an example of how we are focusing our investments to drive sustainable revenue growth potential for our Essential Health business,' said John Young, group president, Pfizer Essential Health ... Pfizer holds the global rights to commercialize Zinforo, with the exception of North America (U.S ... Pfizer Inc....
Sunitinib (Sutent by Pfizer) Malate Market 2016-2021: By Disease - Pancreatic Neuroendocrine Tumors & Kidney ...
Edit Pharmiweb 23 Dec 2016
Sunitinib (Sutent by Pfizer) Malate Market 2016-2021. By Disease - Pancreatic Neuroendocrine Tumors & Kidney Cancer - Research and ... Research and Markets ... ....
Stock Futures Lull, Pfizer Climbs On AstraZeneca Deal
Edit Investors Business Daily 23 Dec 2016
The Dow is up 0.4%, showing a 4.2% gain so far in December ... The Nasdaq is up 2.3% ... In Motion. Pfizer, Hewlett Packard Enterprise. Pfizer (PFE) shed 1.6% after announcing it had completed the acquisition of AstraZeneca's (AZN) late-stage small molecule anti-infective business, a deal involving a $550 million up-front payment and up to $600 in sales-related performance payments. Pfizer shares have been in a mild consolidation since July....
Report: Tom Price traded health-related stocks while in Congress
Edit Atlanta Journal 23 Dec 2016
His stock trades included Amgen Inc., Bristol Meyers Squibb Co., Eli Lilly & Co., Pfizer Inc. and Aetna Inc ... His largest single stock buy was an August 2016 purchase of between $50,000 and $100,000 of an Australian biomedical firm, Innate Immunotherapeutics Inc., whose largest shareholder is a GOP congressman ......
Section Rouge Media Inc. Files Its Filing Statement in Connection...
Edit Topix 23 Dec 2016
Sama Resources Inc./Ressources Sama Inc. and Section Rouge Media Inc. are pleased to announce that Section has filed its filing statement dated December 22, 2016 on SEDAR in connection with its previously-announced reverse take-over, consisting of the acquisition of 100% of the shares of Sama Resources Guinea SARL , a wholly-owned subsidiary of Sama ... ....
BRIEF-Pfizer completes acquisition of small molecule anti-infective business from AstraZeneca
Edit Reuters 23 Dec 2016
* Says completed acquisition of development rights to Astrazeneca's late-stage anti-infective business, primarily outside united states ....
Netflix Stock: This Could Be the Next Trigger for Netflix, Inc.
Edit Profit Confidential 23 Dec 2016
What "The Crown" Means for the Future of Netflix Stock. Netflix, Inc. (NASDAQ.NFLX) showed a gain of one percent Wednesday after analysts praised the success of its new original content "The Crown.". While one percent is hardly a game-breaking surge, what's interesting to note for the future is how Netflix stock came in to this gain ... Miller to predict a boost. The post Netflix Stock. This Could Be the Next Trigger for Netflix, Inc. ... ....
K92 Mining Inc. Reports Technical Disclosure Review
Edit Topix 23 Dec 2016
K92 Mining Inc. was selected for a Technical Disclosure Review by the British Columbia Securities Commission . As a result of this review by the BCSC, K92 is issuing the following news release to clarify our Technical Report disclosure for the Kainantu Project ... ....
Xbrane Biopharma appoints Anders P. Wiklund as strategic advisor
Edit Nasdaq Globe Newswire 23 Dec 2016
Press release. 2016-12-23. Mr. Wiklund has throughout his long career in the Pharmaceutical and Biotechnology Industries, been involved as a dealmaker in numerous transactions. As CEO, Chairman or board member in both private and public companies in the USA and Europe, Mr ... He was also a cofounder of Esperion Therapeutics, which was sold for 1,3 Billion USD to Pfizer ... "We are very excited to have Anders P ... says Anders P. Wiklund. About Xbrane....
Sun Pharma subsidiary invests $13 million in US company
Edit DNA India 23 Dec 2016
A wholly-owned subsidiary of Sun Pharma has acquired 14.58% equity stake in US based scPharmaceuticals Inc ... (about Rs 88 crore) in the US-based scPharmaceuticals Inc....
- 1
- 2
- 3
- 4
- 5
- Next page »
